Moderna expects six major vaccine product launches in the next few years, each with significant addressable markets. The annual global endemic COVID-19 booster market alone is estimated by Moderna to be approximately $15 billon.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MRNA: